Tirzepatide LY3298176 UK Supplier - Research Peptides Manufacturer

Tirzepatide (developmental code: LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for chronic weight management and type 2 diabetes treatment. This innovative peptide compound represents a significant advancement in metabolic disorder therapeutics.

As a research chemical, Tirzepatide demonstrates unique mechanisms of action by simultaneously activating both GIP and GLP-1 receptors. This dual agonism enhances its metabolic effects compared to single-receptor agonists, offering superior glucose control and weight loss potential in preclinical studies.

Key pharmacological properties include:

• Enhanced insulin secretion in glucose-dependent manner
• Reduced glucagon secretion
• Delayed gastric emptying
• Appetite suppression through central nervous system effects

Our Tirzepatide compound is manufactured under strict GMP conditions, ensuring consistent quality for research purposes. The product undergoes rigorous analytical testing including HPLC, MS, and AAA to verify purity and structural integrity.

For researchers looking to buy tirzepatide compound UK, we offer flexible packaging options and bulk quantities to support various study designs. The product is supplied as lyophilized powder in sterile vials with third-party analytical certificates.

Note: This product is intended for research use only, not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.